ライフサイエンスコーパス: methylhistamine

1 ither impromidine (10 microM) nor R(-)-alpha-methylhistamine (10 microM), selective H2 or H3 agonists

2 th bsT and the urinary histamine metabolites methylhistamine and methylimidazole acetic acid (MIMA) w

3 thus inhibited acid secretion, and (r)-alpha-methylhistamine attenuated somatostatin and increased ac

4 f H3R with the selective agonist R-(-)-alpha-methylhistamine dihydrobromide mitigates D2R agonist-ind

5 Interestingly, urinary methylhistamine excretion (p < 0.004) and clinical sympt

6 study was to evaluate urinary histamine and methylhistamine excretion in patients with food allergy

7 icantly higher levels of urine histamine and methylhistamine excretion were found under unrestricted

8 er os in mice for inhibition of brain N(tau)-methylhistamine formation.

9 (r)-alpha-Methylhistamine (H3 agonist) had the opposite effect, de

10 f 36% to 47% at a bsT level of 28.0 mug/L, a methylhistamine level of 231.0 mumol/mol creatinine, and

11 Measurement of urinary n-methylhistamine levels may help to find out patients wit

12 d in vivo (ED50 per os in mice on brain tele-methylhistamine levels).

13 The influence of these factors on urinary methylhistamine (MH) and methylimidazole acetic acid (MI

14 lites methylimidazole acetic acid (MIMA) and methylhistamine (MH) to select patients for bone marrow

15 ptase and the urinary histamine metabolites, methylhistamine (MH), and methylimidazole acetic acid.

16 A specific H3R agonist, alpha-methylhistamine, mimicks the inhibitory effects of hista

17 icant increases in their levels of urinary N-methylhistamine (P < .01) and 2,3-dinor-11beta-prosta

18 lite of prostaglandin D2 (r = 0.98) and Ntau-methylhistamine (r = 0.91), suggesting that the cellular

19 ptors, the effects of the H3 agonist R-alpha-methylhistamine (RAMH) and the H3 antagonist thioperamid

20 Histamine, the HR3 agonist (R) alpha-methylhistamine (RAMH), tetraethyl ammonium (TEA), and 4

21 H3R activation with the agonist R-(-)-alpha-methylhistamine to produce a unique time- and cell type-

22 tic reactions using serial tryptase, urinary methylhistamine (UMH) and clinical information.

23 tor; the major difference was that (R)-alpha-methylhistamine was a low potency agonist of the AXOR35

24 N-methylhistamine was found to be significantly elevated i

25 Urinary histamine and n-methylhistamine were determined by ELISA or tandem mass

26 We determined that the H4R agonist 4-methylhistamine when delivered intratracheally before Ag

27 This mechanism is confirmed using 1- and 3-methylhistamine, which do not electropolymerize, compare

28 not electropolymerize, compared to N(alpha)-methylhistamine, which does.